A Virginia overview of physician-supervised GLP-1 treatment through Astra, including local access context and the cities we cover. Every statistic on this page links to its source.
34.3% of Virginia adults have obesity, per CDC BRFSS 2023 data (95% CI 32.6–36.0%) 4.
Virginia's Medicaid answer is neither a clean yes nor a clean no, and the paperwork is where the difference lives.
Virginia Medicaid's pharmacy benefit does cover FDA-approved anti-obesity drugs for members who meet clinical criteria. This is not a blanket exclusion 1.
But on the Preferred Drug List, "Weight Management Agents" is a closed class in which Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide) are all non-preferred 2. The preferred, no-extra-paperwork options are older appetite suppressants: orlistat/Xenical, phentermine, phendimetrazine, benzphetamine, and diethylpropion. Saxenda is the PDL's designated first-line GLP-1 trial 2.
To get Wegovy or Zepbound approved, DMAS requires a documented physical exam with BMI, a psychiatric/psychosocial evaluation, documented evidence of functional disability, documentation of prior conservative treatment, rule-out of secondary causes such as hypothyroidism, documentation of concurrent conditions, and the prescriber's certification that the member's life is at risk due to obesity 12.
That closed-class rule binds fee-for-service Medicaid and every Cardinal Care managed-care plan identically 1. GLP-1s prescribed for type 2 diabetes (Ozempic, Mounjaro, Trulicity) sit in a separate, far less restrictive drug class with simpler preferred-agent criteria 23.
Virginia Medicaid coverage is restricted as described above: a six-part service-authorization checklist and a Saxenda-first requirement stand between most members and a semaglutide or tirzepatide prescription.
Astra's price is national: compounded semaglutide from $68 per month and compounded tirzepatide from $118 per month on 12-month plans ($816 and $1,416 billed annually), the same price at every dose. There is no Virginia price and no Virginia Beach price.
Median household income statewide is $92,090 (ACS 2024 1-year estimate) 6, a figure pulled upward by Northern Virginia and not representative of, say, the Southside. A single posted national price sidesteps that spread entirely.
This page does not state a Virginia-specific telehealth prescribing rule: DHP's current telehealth regulations were not verified in this pass. Check current telehealth prescribing rules with the Virginia Board of Medicine (Department of Health Professions): dhp.virginia.gov/Boards/Medicine/.
Astra is licensed in all 50 states, including Virginia. Visits and refills are handled online, with medication from a state-licensed US compounding pharmacy.
Virginia added 76,510 residents in the year ending July 1, 2024, reaching 8,811,195, with growth driven almost entirely by international migration 5. The state also has 95 counties plus 38 independent cities, 133 county-equivalent subdivisions, the third-most of any state 7: independent cities such as Virginia Beach sit outside every county, which is why the Virginia Beach guide hangs directly under this hub rather than under a county page.
Astra treats patients in Virginia through state-licensed physicians.
Virginia Beach: local coverage and cost detail.
Only under tight conditions. Virginia Medicaid's Preferred Drug List puts "Weight Management Agents" in a closed class where Wegovy, Zepbound, and Saxenda are all non-preferred — Saxenda is the required first GLP-1 trial. To get a non-preferred GLP-1 approved, DMAS requires a documented BMI exam, a psychiatric/psychosocial evaluation, proof of prior conservative treatment, and a physician's certification that the member's life is at risk due to obesity. This applies identically under fee-for-service and every Cardinal Care managed-care plan.
No — Astra's price is the same nationwide: $68/month for semaglutide and $118/month for tirzepatide, both on 12-month plans ($816 and $1,416 billed annually). Virginia residents pay the identical price as every other state; there is no city or state discount.
Yes. Virginia Medicaid places diabetes-indication GLP-1s (Ozempic, Mounjaro, Trulicity) in a separate drug class from the weight-loss "Weight Management Agents" class, with simpler preferred-agent criteria — essentially a type 2 diabetes diagnosis — and none of the BMI, psychosocial, or functional-disability documentation the weight-loss class requires.
Yes. Astra is licensed to treat patients in all 50 states, including every city and county in Virginia — Virginia Beach patients start care the same way as patients anywhere else in the country.
Virginia Beach is one of 38 independent cities in Virginia — legally outside every county, alongside 95 counties for 133 total county-equivalent subdivisions, the 3rd-most of any state. That's a Virginia-specific quirk of how the Census Bureau classifies the state, and it's why the city page routes directly under /glp-1-by-state/virginia/ rather than nesting under a county.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.